CERO THERAPEUTICS HOLDINGS, INC. Cash and Cash Equivalents
CERO THERAPEUTICS HOLDINGS, INC. (CERO) had Cash and Cash Equivalents of $862.76 thousand as of 2026-06-30, per its 10-Q filed 2026-08-14.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments › Cash and Cash Equivalent
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-14
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $862.76K.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $1.90M.
- 2025-06-30: Cash and Cash Equivalents, at Carrying Value $3.23M; Cash and Cash Equivalents, at Carrying Value as first filed $3.20M.
- 2025-03-31: Cash and Cash Equivalents, at Carrying Value $5.10M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $862.76K 10-Q · filed 2026-08-14 | |
| 2025-09-30 | $1.90M 10-Q · filed 2025-11-19 | |
| 2025-06-30 | $3.23M 10-Q · filed 2026-08-14 | $3.20M 10-Q · filed 2025-08-22 |
| 2025-03-31 | $5.10M 10-Q · filed 2025-05-15 | |
| 2023-12-31 | $96.87K 10-K · filed 2024-04-02 | |
| 2023-09-30 | $119.01K 10-Q · filed 2023-11-09 | |
| 2023-03-31 | $178.09K 10-Q · filed 2023-05-12 | |
| 2022-12-31 | $475.87K 10-K · filed 2024-04-02 | |
| 2021-12-31 | $1.10M 10-K · filed 2023-03-24 | |
| 2021-09-30 | $0.00 10-Q · filed 2021-11-19 | |
| 2021-06-07 | $0.00 10-K · filed 2022-03-24 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| CREATIVE MEDICAL TECHNOLOGY HOLDINGS, INC. (CELZ) | United States | $0.006B | |
| AIM ImmunoTech Inc. (AIM) | United States | $0.006B | |
| TScan Therapeutics, Inc. (TCRX) | United States | $0.008B | -1.23 |
| PharmaCyte Biotech, Inc. (PMCB) | United States | $0.005B | |
| WINDTREE THERAPEUTICS INC /DE/ (WINT) | United States | $0.003B | -0.32 |
| VivoSim Labs, INC. (VIVS) | United States | $0.003B | |
| Senti Biosciences Holdings, Inc. (SNTI) | United States | $0.011B | -0.70 |
| Calidi Biotherapeutics, Inc. (CLDI) | United States | $0.003B | |
| IN8BIO, INC. (INAB) | United States | $0.012B | -0.76 |
| CURIS INC (CRIS) | United States | $0.002B | -0.05 |